Reviewed by Michael Gill, B. Sc.
12 Nephrotic Syndrome Clinical Trials Near Me
Top Hospitals for Nephrotic Syndrome Clinical Trials
Image of Cohen Children's Medical Center in New York.
Cohen Children's Medical Center
New Hyde Park
2Active Trials
2All Time Trials for Nephrotic Syndrome
2022First Nephrotic Syndrome Trial
Image of Children's Hospital of Philadelphia in Pennsylvania.
Children's Hospital of Philadelphia
Philadelphia
2Active Trials
4All Time Trials for Nephrotic Syndrome
2001First Nephrotic Syndrome Trial
Top Cities for Nephrotic Syndrome Clinical Trials
Image of Philadelphia in Pennsylvania.
Philadelphia
4Active Trials
Children's Hospital of PhiladelphiaTop Active Site
Image of Minneapolis in Minnesota.
Minneapolis
4Active Trials
Travere Investigational SiteTop Active Site
Nephrotic Syndrome Clinical Trials by Phase of Trial
Phase 1 Nephrotic Syndrome Clinical Trials
1Active Nephrotic Syndrome Clinical Trials
1Number of Unique Treatments
1Number of Active Locations
Nephrotic Syndrome Clinical Trials by Age Group
Most Recent Nephrotic Syndrome Clinical Trials
Top Treatments for Nephrotic Syndrome Clinical Trials
Treatment Name
Active Nephrotic Syndrome Clinical Trials
All Time Trials for Nephrotic Syndrome
First Recorded Nephrotic Syndrome Trial
Intervention Group
2
2
2022
ADX-629
1
1
2022
VB119
1
1
2022
Sparsentan
1
1
2021
Diuretic Tuner
1
1
2023

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 29th, 2021

Last Reviewed: November 25th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Kerjaschki D, Neale TJ. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis). J Am Soc Nephrol. 1996 Dec;7(12):2518-26. Review. https://pubmed.ncbi.nlm.nih.gov/89897292 Cattran D. Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol. 2005 May;16(5):1188-94. Epub 2005 Mar 30. Review. https://pubmed.ncbi.nlm.nih.gov/158001173 Wang CS, Escoffery C, Patzer RE, McCracken C, Ross D, Rheault MN, Al-Uzri A, Greenbaum LA. A dual efficacy-implementation trial of a novel mobile application for childhood nephrotic syndrome management: the UrApp for childhood nephrotic syndrome management pilot study protocol (UrApp pilot study). BMC Nephrol. 2020 Apr 9;21(1):125. doi: 10.1186/s12882-020-01778-w. https://pubmed.ncbi.nlm.nih.gov/322729014 Ayoub I, Nachman PH. Advances in ANCA-associated vasculitis and lupus nephritis. Nat Rev Nephrol. 2021 Feb;17(2):89-90. doi: 10.1038/s41581-020-00388-x. Review. https://pubmed.ncbi.nlm.nih.gov/333115605 Glassock RJ. Diagnosis and natural course of membranous nephropathy. Semin Nephrol. 2003 Jul;23(4):324-32. Review. https://pubmed.ncbi.nlm.nih.gov/12923720